Advertisement

Biological Products

Open Access
Proteomics and Metabolomics in Kidney Disease, including Insights into Etiology, Treatment, and Prevention
Ruth F. Dubin and Eugene P. Rhee

CJASN March 2020, 15 (3) 404-411; DOI: https://doi.org/10.2215/CJN.07420619

Add to Selected Citations
You have accessRestricted Access
Clinical Trial End Points for Hemodialysis Vascular Access
Surendra Shenoy, Michael Allon, Gerald Beathard, Deborah Brouwer-Maier, Laura M. Dember, Mark Glickman, Celeste Lee, Terry Litchfield, Charmaine Lok, Thomas Huber, Prabir Roy-Chaudhury, Jack Work, Melissa West and Haimanot Wasse

CJASN March 2018, 13 (3) 490-494; DOI: https://doi.org/10.2215/CJN.13321216

Add to Selected Citations
You have accessRestricted Access
Defining Glomerular Disease in Mechanistic Terms: Implementing an Integrative Biology Approach in Nephrology
Laura H. Mariani, William F. Pendergraft and Matthias Kretzler

CJASN November 2016, 11 (11) 2054-2060; DOI: https://doi.org/10.2215/CJN.13651215

Add to Selected Citations